All In Biotech

Drug Trial Radar · NCT04174716

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

An Open-label, Multi-center, Phase 1b/2a Basket Trial of IDX-1197 in Patients With Homologous Recombination Repair Mutated Solid Tumors

Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

108

Actual

Start

Nov 6, 2019

Primary completion

Mar 31, 2023

Study completion Jun 28, 2024

Sponsor

Lead sponsor
Idience Co., Ltd.Industry
Sponsor type
Industry
First posted
Nov 22, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase 1b/2a basket trial to assess safety and efficacy of IDX-1197 in patients with HRR mutation. There are two parts to this study: Phase 1b, IDX-1197 dose-selection study to determine RP2D and Phase 2a, non-randomized parallel dose expansion study to confirm RP2D.

Conditions

  • Solid Tumors
  • Homologous Recombination Repair Gene Mutation
  • Homologous Recombination Deficiency

Interventions

  • IDX-1197Drug

    Until progression or unacceptable toxicity develops

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. objective response rate (ORR)Time frame: Up to 24 weeks

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Inje University Haeundae Hospital

    Busan, South Korea

  • Dong-a University Hospital

    Busan, South Korea

  • Pusan National University Yangsan Hospital

    Busan, South Korea

  • Gachon University Gil Medical Center

    Incheon, South Korea

  • Cha University Bundang Medical Center

    Seongnam-si, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    Seoul, South Korea

  • Seoul Metropolitan Government Seoul National University Boramae Medical Center

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • National Cancer Centre

    Goyang, Gyeongggi-do, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

  • Ajou University Hospital

    Suwon, Gyeonggi-do, South Korea

  • Gyeongsang National University Hospital

    Jinju, Gyeongsangnam-do, South Korea

  • Chonnam National University Hwasun Hospital

    Hwasun, Jeollanam-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.